Angiogenesis blockade as therapy for hepatocellular carcinoma: progress and challenges

J Gastroenterol Hepatol. 2011 Jan;26(1):4-6. doi: 10.1111/j.1440-1746.2010.06590.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Animals
  • Berberine / therapeutic use*
  • Carcinoma, Hepatocellular / blood supply
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / metabolism
  • Down-Regulation
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism
  • Humans
  • Liver Neoplasms / blood supply
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / metabolism
  • Neovascularization, Pathologic / metabolism
  • Neovascularization, Pathologic / prevention & control*
  • Neovascularization, Physiologic / drug effects*
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Angiogenesis Inhibitors
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Berberine